FDA Peptide Regulatory Status (2025) is part of the Novusyn Research editorial desk. Independent tracker of FDA peptide regulation in 2025 — drug-shortage list status, 503A/503B compounding boundaries, enforcement actions, and GLP-1 court rulings. This prerendered HTML exists so crawlers see route-specific content before the client app hydrates.
For adjacent coverage, see the news desk, clinical trials tracker, regulation tracker, guides library, and the compound directory. Novusyn Research publishes neutral, research-only reference material and does not sell compounds or provide medical advice.